Why the study?
Patients with a previous MI may be at particularly high risk for MACE and death after ACS, prompting study of alirocumab's effects according to history of MI.
Does alirocumab reduce major adverse cardiovascular events in patients with recent ACS according to previous history of MI?
Does alirocumab reduce major adverse cardiovascular events in patients with recent ACS according to previous history of MI?
In patients with recent ACS, alirocumab provides consistent relative risk reductions for MACE, with a greater absolute benefit observed in those with a history of previous MI.
Answers are grounded in this paper and cite their sources.
Supports targeting alirocumab post-ACS for greater absolute benefit in prior-MI patients; extends RCT subgroup evidence for risk stratification.
BACKGROUND: After acute coronary syndrome (ACS), patients with a previous myocardial infarction (MI) may be at particularly high risk for major adverse cardiovascular events (MACE) and death. We studied the effects of the PCSK9 inhibitor alirocumab in patients with recent ACS according to previous history of MI. METHODS: The ODYSSEY OUTCOMES trial compared alirocumab with placebo, beginning 1 to 12 months after ACS with median 2.8-year follow-up. The primary MACE outcome comprised death from coronary heart disease, nonfatal MI, fatal or nonfatal ischemic stroke, and hospitalization for unstable angina. Of 18,924 patients, 3633 (19.2%) had previous MI. Estimated absolute risk reductions with alirocumab were numerically greater with vs without previous MI (MACE, 1.91% vs 1.42%; death, 1.35% vs 0.41%). CONCLUSIONS: A previous history of MI places patients with recent ACS at high risk for recurrent MACE and death. Alirocumab reduced the relative risks of these events consistently in patients with or without previous MI but with numerically greater absolute benefit in the former subgroup. (ODYSSEY OUTCOMES: NCT01663402).
No takes yet. Share an insight, caveat, or question.
Chiang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: